O
ESRX

OrbiMed’s Express Scripts Holding Company ESRX Stock Holding History

OrbiMed’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,451,900
Closed -$102M – 146
2016
Q3 		$102M Sell
1,451,900
-246,700
-15% -$18.4M 1.17% 29
2016
Q2 		$129M Sell
1,698,600
-722,400
-30% -$53.1M 1.34% 25
2016
Q1 		$166M Buy
2,421,000
+239,000
+11% +$17.2M 1.75% 18
2015
Q4 		$191M Buy
2,182,000
+840,000
+63% +$72M 1.73% 18
2015
Q3 		$109M Hold
1,342,000
– – 1.1% 32
2015
Q2 		$119M Buy
1,342,000
+9,000
+0.7% +$786K 1% 32
2015
Q1 		$116M Sell
1,333,000
-974,000
-42% -$81.7M 0.99% 32
2014
Q4 		$195M Buy
2,307,000
+209,000
+10% +$16.3M 1.87% 22
2014
Q3 		$148M Buy
2,098,000
+19,000
+0.9% +$1.35M 1.55% 27
2014
Q2 		$144M Sell
2,079,000
-18,000
-0.9% -$1.27M 1.69% 24
2014
Q1 		$157M Buy
2,097,000
+810,000
+63% +$60.7M 1.94% 20
2013
Q4 		$90.4M Sell
1,287,000
-496,000
-28% -$32.4M 1.33% 26
2013
Q3 		$110M Sell
1,783,000
-124,170
-7% -$8.03M 1.97% 18
2013
Q2 		$118M Buy
+1,907,170
New +$115M 2.5% 13

Other funds holding ESRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OrbiMed's ESRX Position: Q4 2016 in Review

OrbiMed sold out of Express Scripts Holding Company (ESRX) in Q4 2016, closing a stake of 1,451,900 shares — an estimated $102M sold.

OrbiMed first reported a position in ESRX in Q2 2013 and held it in 14 quarters. The position peaked at $195M in Q4 2014. 1,151 funds tracked by Wall St. Rank hold ESRX as of Q4 2016.

  • OrbiMed reported no remaining Express Scripts Holding Company position as of Q4 2016 after selling out during the quarter.
  • OrbiMed sold 1,451,900 Express Scripts Holding Company shares in Q4 2016, an estimated $102M.
  • OrbiMed first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 14 quarters.
  • OrbiMed's Express Scripts Holding Company position peaked at $195M in Q4 2014.
  • 1,151 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2016.

Based on OrbiMed's 13F filing for Q4 2016, filed 14 Feb 2017.